In a study, PDAC cells treated with 5-FU or abraxane showed overexpression of H19 compared with non-treated cells, which suggested that H19 may be associated with drug resistance in pancreatic cancer cells (Yoshimura et al. 2018). This evidence concerns the gene H19 and pancreatic neoplasm.